|
|
|
Krasnogorskaya V.N., Gusev A.N., Gusevа E.V. CITOFLAVIN USE IN MODERN OPHTHALMIC PRACTICE IN THE TREATMENT OF NONSTABILIZED PRIMARY OPEN-ANGLE GLAUCOMA IN SEVERE STAGEComplex therapy of primary open-angle glaucoma in the severe stage, including surgery (sinustrabeculectomy and posterior trepanation of sclera), then medication (subconjunctival injection of the drug Citoflavin 10 mg (0,5ml)) and physiotherapy (magnitolaserstimulation of the optic nerv), followed by 10 days, was conducted. 71 patients (71 eyes) were examined. The results of complex treatment showed the improvement of visual functions and stabilization of glaucomatous process in 87 percent of cases.Key words: glaucoma, magnitolaserstimulation, Citoflavin.
References:
1. Nesterov, A.P. Primary open-angle glaucoma: pathogenesis and principles of treatment / A.P. Nesterov // Clinical ophthalmology. — V.1. — No1. — 2000. — P. 4–5.
2. Bunin, A.Ya. Metabolic factors of pathogenesis of primary open-angle glaucoma / A.Ya Bunin // Glaucoma at a turn of the millennium, results and prospects: Science-pract. conf. — M.: 1999. — P. 9–12.
3. Safina, Z.M. Electrostimulation in clinic of eye diseases / Z.M. Safina. — Ufa 2000. — P. 5–7.
4. Bunin, A.Ya. Metabolic factors of pathogenesis of primary open-angle glaucoma / A.Ya. Bunin // Materials of the scientific and practical conference "Glaucoma at a Turn of the Millennium, Results and Prospects". — 1999. — P. 9–12.
5. Nesterov, A.P. Primary glaucoma / A.P. Nesterov. — M.: Medicine. — 1995. — P. 256–259.
About this article
Author:
Year: 2014
|
|
Editor-in-chief |
Sergey Aleksandrovich MIROSHNIKOV |
|
|